• Aucun résultat trouvé

Phase II/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas - PRODIGE 19 - FFCD1103 - ADCI002.

N/A
N/A
Protected

Academic year: 2021

Partager "Phase II/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas - PRODIGE 19 - FFCD1103 - ADCI002."

Copied!
10
0
0

Texte intégral

Loading

Figure

Figure 1 Therapeutic scheme for the protocol.
Figure 2 Scheme for trial analysis.

Références

Documents relatifs

Effect of Pembrolizumab after stereotactic body radiotherapy vs Pembrolizumab alone on tumor response in patients with advanced non-small cell lung Cancer: results of the

Co mplete list of all benthic diat oms identifi ed from the stream and lak es wi th rela tive abun dances a verage d a cr oss the three dates (strea ms) o r lakes in a b asin.. Str

Instructions : Il est rappelé que la qualité de la rédaction, la clarté et la précision de raisonnements entreront pour une part importante dans l’appréciation des

[r]

wind phase was measured only for one field at ground and the zero wind phase of the other field was obtained by symmetry using a mathematical model of the interferometer, it

L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des

Methods: This study was conducted on RNA from initial biopsies, in a prospective trial of neoadjuvant chemotherapy in 327 patients with inoperable breast cancer. Four

results of a controlled, prospective, randomised, multicentre trial. Chemotherapy prolongs survival in inoperable pancreatic carcinoma. Prospective randomized double-blind trial